Effortless and Efficient COPD Assessment for Adult Smokers This device features an easy-to-read LCD screen that presents various parameters, including the percentage of predicted FEV1. It can also depict a male or female smoker to illustrate the potential harm caused by smoking. The PulmoLife COPD Screening and Lung Age Meter provides a straightforward and efficient method for evaluating adult smokers for COPD symptoms, making it ideal for general practitioners in clinics or during home visits. The PulmoLife helps conserve time and resources by quickly pinpointing patients who might need comprehensive spirometry testing. Ideal for: FEV1 assessment initiatives; Detecting early COPD indicators in smokers over 40 or those exhibiting symptoms; Assisting at-risk smokers in quitting; FEV1 and FEV1 % Predicted: Forced Expiratory Volume in the First Second of Expiration. FEV1 is widely recognized as an effective diagnostic measure for early COPD detection. By comparing results to predicted values and using the patient's FEV1 as a percentage of these values (FEV1 % predicted), the presence and severity of COPD can be assessed. ‘Lung Age’: Beyond comparing patient FEV1 results with standard reference values, the ‘Lung Age’ estimation can effectively demonstrate to smokers the impact of smoking on their lungs in an understandable manner. This estimation is derived from the patient's FEV1 results and predicted values. For instance, a 40-year-old male smoker, 5’9" (1.75m) tall, with an FEV1 of 3.4L, would have an estimated ‘Lung Age’ of 52 years, as this FEV1 is equivalent to 100% of the expected value for a 52-year-old. Features: Quick, easy operation; Clear LCD screen; % Predicted FEV1; Identifies patients who may need comprehensive spirometry; Visual representation of smoking effects; Provides an precise lung age estimation; Dependable and cost-effective;
Related
Related